Global Health Center

Philip E. Castle, Ph.D.

 Castle profile picture Professor, Department of Epidemiology & Population Health
 

Dr. Philip Castle is a Professor in the Department of Epidemiology and Population Health at Albert Einstein College of Medicine, Bronx, N.Y., USA and the Executive Director and Co-Founder of the Global Coalition Against Cervical Cancer (Arlington, VA, USA). He is also a Visiting Professor at the Cancer Institute/Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College in Beijing, P.R. China and was Honorary Professor at the University of New South Wales, Sydney, Australia. Previously, Dr. Castle was the Chief Scientific Officer of the American Society for Clinical Pathology (ASCP) (2011-2). He was a Senior, Tenured Investigator (2010-11) and Tenure-Track Investigator (2003-10) in the Division of Cancer Epidemiology and Genetics (DCEG) at the U.S. National Cancer Institute (NCI). He received his Ph.D. in Biophysics in 1995 and M.P.H. in Epidemiology in 2000 from the Johns Hopkins University. 

While at the NCI, he was the lead investigator on several epidemiologic studies, including the Mississippi Delta Project, The HPV Persistence and Progression Cohort and The Guidelines Cohort at Kaiser Permanente Northern California (KPNC), and the Anal Cancer Screening Study. He remains co-PI of The Guidelines Cohort at KPNC and of the Low-Cost Molecular Cervical Cancer Screening Study in China. Dr. Castle is currently conducting cervical cancer screening and treatment research in Australia, Papua New Guinea, Norway, El Salvador, Brazil, Peru, Colombia, Mexico, India, Zambia, Cameroon, and Rwanda as well as the U.S. 

Dr. Castle has published over 300 papers on HPV and cervical cancer and has contributed articles to such prestigious journals as the New England Journal of Medicine, Lancet, Lancet Oncology, Journal of the National Cancer Institute, British Medical Journal, JAMA, Archives for Internal Medicine, and Cancer Research. He currently serves on the editorial boards of the Journal of Infectious Diseases, Journal of Lower Genital Tract Disease, HPV, and Cancer Prevention Research. Dr. Castle has served as an invited speaker or session chair in many forums, including for the American Association for Cancer Research, International Papillomavirus Society, and the European Union on Genital Infection and Neoplasia. 

Dr. Castle regularly participates in the development of national and international guidelines for cervical cancer prevention. Dr. Castle serves as a consultant for several countries, including Nicaragua, Uganda, and Rwanda, on the development of national cervical cancer prevention programs and is participating in pilot/demonstration projects in El Salvador and Haiti. He was recently a member of the Centers for Disease Control and Prevention’s (CDC) National Breast and Cervical Cancer Early Detection and Prevention (NBCCEDP) Advisory Committee. Dr. Castle is a member of the Board of Directors of the American Society for Colposcopy and Cervical Pathology (ASCCP). He serves as steering committee member of the American Society for Clinical Oncology’s Cervical Cancer Resource Stratified Secondary Prevention Guideline Panel. 

For his work in cervical cancer prevention, Dr. Castle has received (1) An EUROGIN Distinguished Service Award (2006); (2) a NIH Merit Award for introduction of HPV testing into low-resource settings in the U.S. (2007); (3) a Distinguished Scientific Achievement Award from the ASCCP (2010), its highest honor; (4) The Arthur S. Flemming Award for Exceptional Achievement in Federal Government Service for Applied Science, Engineering and Mathematics (2010); and (5) NCI Cancer Prevention Fellowship Program Distinguished Alumni (2017-8). 


 ghfperu 

 The Einstein Library is a great resource for global health information - check it out! 

Photo Gallery 

 
Click here to log in